Insys Therapeutics Reports Preliminary Estimated Revenues

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Insys Therapeutics Reports Preliminary Estimated Revenues from Subsys for the First Quarter 2016

PHOENIX, April 11, 2016 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ: INSY ) ("Insys" or "the Company") today announced that its preliminary estimated revenues from Subsys ® (fentanyl sublingual spray) for the first quarter of 2016 will be in the range of $61 million to $62 million. Estimated revenues for the quarter reflect a decline in demand, as Subsys prescription volumes were down, as well as a reduction in wholesale inventory levels.  The Company estimates the decrease in wholesale channel inventory levels to be in the range of $7 million. 

The Company believes that heightened publicity surrounding the national opioid epidemic has resulted in a sensitivity by some healthcare providers to prescribe opioids.  The Company expects the Subsys prescription decline is close to stabilizing.  At the current sales levels, the Company believes it will remain profitable and intends to pursue all of its research and development projects.

Today’s preliminary estimate of revenues from Subsys, which is unaudited, is based on management's preliminary financial analysis.

About Insys Therapeutics, Inc.

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using proprietary sublingual spray technology and capabilities to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets one product, Subsys ® (fentanyl sublingual spray). The Company recently submitted a New Drug Application to the U.S. Food and Drug Administration for Syndros™ (dronabinol oral solution), a proprietary, orally administered liquid formulation of dronabinol that Insys believes has distinct advantages over the current formulation of dronabinol in soft gel capsule. Insys is developing a pipeline of sublingual sprays, as well as pharmaceutical cannabidiol.

Subsys ® and Syndros™ are trademarks of Insys Therapeutics, Inc.

Forward-Looking Statements This press release contains forward-looking statements including (i) our preliminary estimate of first quarter 2016 revenue and the financial analysis related thereto, (ii) the Company’s belief that the opioid epidemic has resulted in a sensitivity by some healthcare providers to prescribe opioids; (iii) the Company’s belief that prescription trends indicate Subsys is close to stabilizing; and (iv) the Company’s belief that it will be profitable and will continue to pursue all of its research and development projects.  These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release; actual results may differ materially from those in these forward-looking statements as a result of various factors, many of which are beyond our control. These factors include, but are not limited to risk factors described in the Company’s filings with the United States Securities and Exchange Commission, including those factors discussed under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2015 and subsequent updates that may occur in our Quarterly Reports on Form 10-Q.  Forward-looking statements speak only as of the date of this press release and we undertake no obligation to publicly update or revise these statements, except as may be required by law.

Contact: Lisa M. Wilson President In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Protein Now! Gains Clinician Attention, With Caveats

Updated Category News Views 91

A Small Bottle Has Drawn a Crowd Protein powder tubs have been cluttering kitchens for years; a 3.38-fluid-ounce shot is a cleaner answer to the same daily hassle. NutraBio Labs says more than 800 physicians, nurse practitioners, and physician associates had added PROTEIN NOW! to their individual FrontrowMD patient pages as of November 2026. That earned the product a...

Continue Reading
Branch's Fast 500 Rank Signals Payroll Platform Reach

Updated Category News Views 58

Six straight appearances on Deloitte's Fast 500 is not random confetti; it says Branch has kept finding customers while plenty of fintech outfits were busy shrinking their ambitions. The Tampa-based workforce-payments company landed at No. 146 in the 2026 ranking, which measures fiscal-year revenue growth from 2022 through 2025. That is a respectable showing in a list...

Continue Reading
SoCalGas Data Program Puts Metering Case Into Focus

Updated Category News Views 61

Buried beneath the usual utility-company polish is a pretty sensible idea: find waste before a customer gets walloped by a bill. SoCalGas says its Advanced Meter Analytics program has helped customers avoid an estimated $11 million in unnecessary natural-gas costs since 2019. That is not a number likely to move Sempra’s earnings by itself, and nobody should pretend...

Continue Reading
Perigon Builds Its Investment Bench for the Next Leg

Updated Category News Views 110

Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...

Continue Reading
Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 87

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Cleveland Picks Golden Key for Citywide Leadership Training

Updated Category News Views 247

A Citywide Bet on Better Management Municipal management rarely grabs headlines until something breaks, which is precisely why Cleveland's decision to bring in Golden Key Group deserves a closer look. Announced November 20, 2026, the arrangement calls for GKG to design and deliver a citywide management training program through Cleveland's Department of Personnel and Human...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 27

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 95

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 61

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading
Lara Kirchner's Surgical Leadership Earns Recognition

Updated Category News Views 64

Surgical care gets judged in the quiet moments nobody puts on a plaque: a sterile instrument ready when it must be, a handoff done cleanly, a team that does not let a rushed schedule turn into a bad outcome. That is why Lara L. Kirchner's recognition as a Pinnacle Professional of the Year deserves a more serious look than the usual congratulatory confetti. Kirchner is...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Jaw Clicking and TMJ: Expert Advice

Updated Category News Views 43

An Unseen Complication: The Problem with Jaw Clicking When something's wrong, especially with the body's mechanics, there's usually a sound telling you so. Hearing a click every time you chew? Dr. Georgia Knotek from Greenfield knows all about it. In a recent HelloNation article, she dives into this unsettling symptom that many shrug off but shouldn't. Let's talk about...

Continue Reading
Aduro Clean Technologies Expands Leadership and Marketing Initiatives

Updated Category News Views 149

Aduro Clean Technologies Enhances Leadership and Marketing Strategies Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (NASDAQ: ADUR), has made significant strides in its journey towards commercialization. The Company, which specializes in clean technology to recycle lower-value feedstocks like waste plastics and heavy bitumen, is strengthening its team as...

Continue Reading
Katahdin Bankshares Corp. Reveals Increased Dividend Payment

Updated Category News Views 145

Katahdin Bankshares Corp. Declares Fourth Quarter Dividend Katahdin Bankshares Corp. (OTCQX: KTHN), the parent company of Katahdin Trust Company, recently announced an exciting update regarding its quarterly dividend. In an effort to reward its loyal shareholders, the company has declared a cash dividend of $0.2025 per share for the fourth quarter. This payment is...

Continue Reading
Symbotic Inc. Faces Class Action Lawsuit Amid Investor Losses

Updated Category News Views 336

Class Action Lawsuit Filed Against Symbotic Inc. In recent developments, a law firm recognized nationally, Bronstein, Gewirtz & Grossman, LLC, has taken a significant step by notifying investors about a class action lawsuit involving Symbotic Inc. (NASDAQ: SYM). This legal action targets certain officers of the company while focusing on protecting the interests of...

Continue Reading
Persona-Triangle Welcomes Arron Yount as Its New CEO

Updated Category News Views 156

Persona-Triangle Appoints Arron Yount as CEO Persona-Triangle recently announced the appointment of Arron B. Yount as its new Chief Executive Officer. With a robust background in operations and a history of enhancing multi-divisional businesses, Yount is expected to lead the company into a new chapter of growth and innovation. Leadership Experience Driving Change Bringing...

Continue Reading